| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.05. | Edwards names a new CFO | ||
| 04.05. | CVRx enrolls first patient in study of Barostim therapy for heart failure | ||
| 04.05. | Inspire Medical slashes 2026 guidance amid reimbursement uncertainty | ||
| 04.05. | MMI completes first robotic-assisted procedure in Alzheimer's patient | ||
| 04.05. | Sensome reports positive findings for clot-sensing guidewire | ||
| 04.05. | Masimo shareholders give green light to $10B acquisition by Danaher | ||
| 04.05. | Insulet initiates study of fully closed-loop insulin delivery in type 2 diabetes | ||
| 04.05. | Olympus inks distro deal with EndoRobotics to boost EndoTherapy portfolio with robot-assisted tech | ||
| 04.05. | Edwards has 10-year data supporting durability of Resilia tissue for heart valve tech | ||
| 01.05. | InspireMD recalls CGuard Prime 135 cm stent delivery system in US, gets nod to study neuroprotection tech | ||
| 01.05. | Zeta Surgical earns FDA nod for surgical navigation instruments | ||
| 01.05. | Agitated Solutions wins CE mark for cardiac microbubble generator device | ||
| 01.05. | Sonire kicks off study of focused ultrasound therapy for treating cancer | ||
| 01.05. | iRhythm posts Q1 beats, ups guidance with next-gen Zio algorithm coming | ||
| 01.05. | Johnson & Johnson has a new VP of investor relations | ||
| 01.05. | Align Technology announces $200M share repurchase | ||
| 01.05. | Philips gets FDA clearance for flexible MR coil | ||
| 01.05. | Resmed Q3 earnings exceed estimates, CFO's retirement announced | ||
| 01.05. | Stryker results miss after Q1 cyberattack, company sticks with guidance | ||
| 30.04. | Senseonics announces $80M public offering | ||
| 30.04. | Stryker beats The Street despite Q1 cyberattack, sticks with guidance | ||
| 30.04. | Dexcom stock dips after hours despite Q1 beats, 15% sales growth | ||
| 30.04. | Orchestra BioMed wins FDA breakthrough nod for pacemaker in hypertension | ||
| 30.04. | Baxter posts Street-beating Q1 results, reiterates guidance | ||
| 30.04. | SetPoint to evaluate neuromod for multiple sclerosis |